Clinical Trial Update: MS-553 in Diabetic Retinopathy Patients With Central Involved Macular Edema [Phase 1]

View source ↗

Summary

This clinical trial update indicates that the investigational drug MS-553 is in Phase 1 testing for diabetic retinopathy with central-involved macular edema and…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus Type with Diabetic Macular Edema
• Diabetic Macular Edema
• Diabetic Retinopathy
• Macular Edema

Drugs mentioned

• MS-553 (MS-553)

Snippet

Sponsor: Shenzhen MingSight Relin Pharmaceuticals Co., Ltd. | Conditions: Diabetic Macular Edema, Macular Edema | Phase 1 | Status: RECRUITING